 LA JOLLA, Calif., Dec. 05, 2022 GLOBE NEWSWIRE MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market NASDAQ:MNOV and the JASDAQ Market of the Tokyo Stock Exchange Code Number: 4875, today announced that positive results from a secondary analysis of a Phase 2 trial of MN-166 ibudilast in alcohol use disorder AUD ... The post MediciNova Announces Positive Results from Secondary Analysis of Phase 2 Trial of MN-166 ibudilast Published in The American Journal... 